Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal Tumors.
Anna M VargheseDana B CardinJonathan HerschAl B BensonHoward S HochsterLukas MakrisKensuke HamadaJordan D BerlinLeonard B SaltzPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Tolerability and activity observed in this phase I trial support further investigation of the FTD/TPI-irinotecan-bevacizumab combination in previously treated mCRC.